MEDICINE: Court Must OK Change; Center Failed To Attract Needed Patients
An agreement calls for a new owner and new clinical provider for San Diego County’s only proton therapy center amid patient volumes not meeting projections.
BIOTECH: Capital Will Fund Studies; Co. To Expand Sales Team
Exagen Diagnostics Inc., a Vista-based company that makes tests to diagnose lupus, has received $48 million from investors and lenders to boost commercialization. The dollars come on the promise of a new product, despite the company’s rocky track record for product development.
BIOTECH: Co. to Rely On Federal Funding; Insurance Coverage Will Be Acid Test
Patrik Schmidle holds up a clear plastic box with a tiny microchip, hardly visible, at its center.
PHARMA: Allergan, Imprimis Trade Accusations in Dispute
A Goliath in the biotech industry is suing San Diego drugmaker Imprimis Pharmaceuticals, alleging the company is selling new drugs without regulatory approval. Imprimis said the claims are bogus and a move by the biotech giant to quash competition.
San Diego-based TruMed Systems has released its AccuVax vaccine system that the company says streamlines vaccine workflow, saves nurses time and protects against medical errors.
Kaiser Permanente in November will launch two additional Kaiser-staffed retail clinics in regional Target stores.
San Diego-based drug developer Abide Therapeutics has hired Sapna Srivastava as its chief financial and strategy officer.
Technology developed by San Diego startup Lymber Inc. is deploying nationwide later this month following the company’s acquisition by Mindbody Inc.
HEALTH: Five-Center Effort to Boost Efficiencies Including Trials, Treatments
Five-Center Effort to Boost Efficiencies Including Trials, Treatments
A 2.3 percent excise tax on all medical devices sold in the U.S. could resume in 2018, sparking a renewed push among San Diego’s medtech hub to scrap the measure.
San Diego staffing company Eastridge Workforce Solutions has acquired Operon Resource Management, which provides staffing solutions for health care product manufactures.
BIOTECH: Commercial Focus May Slow Wider Innovation
As public funding for medical research grows scarce, academics in San Diego are increasingly turning to Big Pharma to help them translate science into dollars.
La Jolla-based Sophiris Bio Inc. has borrowed $7 million from Silicon Valley Bank to help finance late stage clinical trials and to extend the company’s cash runway through 2019.
Akcea Therapeutics, a spinout and subsidiary of Carlsbad drugmaker Ionis Pharmaceuticals, has asked for the green light from regulators to sell one of its drugs in Canada.